Quarterly report pursuant to Section 13 or 15(d)

Schedule of Stock-Based Compensation Expense (Details)

v3.23.1
Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense $ 3,208 $ 3,835
2018 Equity Plan [Member] | Cost Of Revenue [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 12
2018 Equity Plan [Member] | Selling and Marketing Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 223 265
2018 Equity Plan [Member] | General and Administrative Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 2,512 3,201
2018 Equity Plan [Member] | Research and Development Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 70 71
PAVmed Inc 2014 Equity Plan [Member] | Selling and Marketing Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 133 175
PAVmed Inc 2014 Equity Plan [Member] | General and Administrative Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 156 68
PAVmed Inc 2014 Equity Plan [Member] | Research and Development Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 95 55
PAVmed Inc 2014 Equity Plan [Member] | Cost Of Revenue Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense $ 7